We have not seen a change in the side effect profile on 480 mg vs 240 mg dosing in the adjuvant or metastatic setting so far which surprised me a bit. What about others?

It seems that our experiences thus far have been variable with the 480mg q 4 wk dosing, and certainly seems that the low grade flu like sx can an education point that we can all cover with our patients whether they are just starting tx or transitioning from another dosing regminen. Fortunately, in our observations, they have been short lived (usually several days) and respond to no intervention or supportive care such as acetaminophen or ibuprofen.

There are several patients in our practice who have either experienced a mild infusion reaction or post treatment fatigue and myalgia, we are premedicating these patients with dexamethasone or solumedrol IV and they have no furhter issues during or post infusion. 2 other patients have had some occassional GI upset resolvable with a medrol dose pak post tx.